HomeComparePRWYF vs MRK

PRWYF vs MRK: Dividend Comparison 2026

PRWYF yields 294.12% · MRK yields 2.76%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 PRWYF wins by $1325.65M in total portfolio value
10 years
PRWYF
PRWYF
● Live price
294.12%
Share price
$0.68
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$1325.71M
Annual income
$794,394,573.14
Full PRWYF calculator →
MRK
Merck & Co. Inc.
● Live price
2.76%
Share price
$120.31
Annual div
$3.32
5Y div CAGR
32.7%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$56.8K
Annual income
$9,798.13
Full MRK calculator →

Portfolio growth — PRWYF vs MRK

📍 PRWYF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodPRWYFMRK
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, PRWYF + MRK cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
PRWYF pays
MRK pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

PRWYF
Annual income on $10K today (after 15% tax)
$25,000.00/yr
After 10yr DRIP, annual income (after tax)
$675,235,387.17/yr
MRK
Annual income on $10K today (after 15% tax)
$234.56/yr
After 10yr DRIP, annual income (after tax)
$8,328.41/yr
At 15% tax rate, PRWYF beats the other by $675,227,058.76/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of PRWYF + MRK for your $10,000?

PRWYF: 50%MRK: 50%
100% MRK50/50100% PRWYF
Portfolio after 10yr
$662.88M
Annual income
$397,202,185.64/yr
Blended yield
59.92%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on MRK right now

PRWYF
No analyst data
Altman Z
1.0
Piotroski
4/9
MRK
Analyst Ratings
25
Buy
11
Hold
1
Sell
Consensus: Buy
Price Target
$128.54
+6.8% upside vs current
Range: $100.00 — $150.00
Altman Z
4.0
Piotroski
6/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

PRWYF buys
0
MRK buys
0
No recent congressional trades found for PRWYF or MRK in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricPRWYFMRK
Forward yield294.12%2.76%
Annual dividend / share$2.00$3.32
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%32.7%
Portfolio after 10y$1325.71M$56.8K
Annual income after 10y$794,394,573.14$9,798.13
Total dividends collected$1272.08M$28.9K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: PRWYF vs MRK ($10,000, DRIP)

YearPRWYF PortfolioPRWYF Income/yrMRK PortfolioMRK Income/yrGap
1← crossover$40,112$29,411.76$11,206$366.19+$28.9KPRWYF
2$153,177$110,257.74$12,650$502.35+$140.5KPRWYF
3$557,403$393,502.97$14,407$694.19+$543.0KPRWYF
4$1,934,676$1,338,254.83$16,585$967.82+$1.92MPRWYF
5$6,411,147$4,341,043.67$19,342$1,363.89+$6.39MPRWYF
6$20,304,218$13,444,291.14$22,913$1,947.19+$20.28MPRWYF
7$61,518,331$39,792,817.18$27,662$2,823.89+$61.49MPRWYF
8$178,502,627$112,678,013.16$34,159$4,173.35+$178.47MPRWYF
9$496,557,087$305,559,276.51$43,337$6,308.80+$496.51MPRWYF
10$1,325,710,656$794,394,573.14$56,776$9,798.13+$1325.65MPRWYF

PRWYF vs MRK: Complete Analysis 2026

PRWYFStock

Prodways Group SA manufactures and sells industrial and professional 3D printers in France and internationally. The company operates in two segments, Systems and Products. It offers machines, such as 3D printing systems that include lost wax, DLP15resin, and laser sintering; and other related premium materials and services, as well as offers 3D design, simulation, and optimization software. The company also provides metal and plastic parts; orthopedic insoles for podiatry application; orthodontic pieces and dental trays, mouthpieces dental application; and hearing aid tips and custom hearing protection products for audiology application. It serves aerospace and defence, healthcare, automotive, consumer goods, and jewellery sectors. Prodways Group SA was founded in 2013 and is headquartered in Paris, France.

Full PRWYF Calculator →

MRKHealthcare

Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.

Full MRK Calculator →
📬

Get this PRWYF vs MRK comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

PRWYF vs SCHDPRWYF vs JEPIPRWYF vs OPRWYF vs KOPRWYF vs MAINPRWYF vs JNJPRWYF vs ABBVPRWYF vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.